Share: Facebook Twitter LinkedIn
Activity Provided By:

CE Concepts

Applying ADAURA in Practice: Implications For Early Stage EGFRM NSCLC

Access Activity

Overview / Abstract:

This educational initiative is targeted to medical oncologists, thoracic surgeons, pulmonologists, radiation oncologists and molecular pathologists who are involved in diagnosis of early stage NSCLC that is surgically resectable with curative intent. In addition to examining the latest ADAURA trial data and the potential utility of adjuvant osimertinib in stage IB-IIIA EGFRm NSCLC, the practice-changing implications of these results will also be explored from a variety of perspectives with three different specialties. There will be interactive discussion regarding practical strategies to ensure early biomarker testing to such that patients with EGFR-mutant disease can potentially benefit from adjuvant targeted therapies.


Apr 01, 2022


Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME


Online, Webinar / Webcast / Video

Credits / Hours




Is This Activity Certified for "Live" Credit?


Presenters / Authors / Faculty

Lecia V. Sequist, MD, MPH (Moderator)
Harvard Medical School
Massachusetts General Hospital
Boston, Massachusetts

Charu Aggarwal, MD, MPH
Leslye M. Heisler Associate Professor for Lung Cancer Excellence
University of Pennsylvania Abramson Cancer Center
Philadelphia, Pennsylvania

Dara Aisner, MD, PhD
Associate Professor, Department of Pathology
University of Colorado Hospital
School of Medicine
Aurora, Colorado

David Tom Cooke, MD, FACS
Associate Professor of Surgery
Chief, Division of General Thoracic Surgery
Vice Chair for Faculty Development & Wellness
UC Davis Health
Sacramento, California

Activity Specialities / Related Topics

Pulmonary Medicine / COPD, Oncology / Cancer / Radiation Therapy

Sponsors / Supporters / Grant Providers

Supported by an independent educational grant from AstraZeneca.

Keywords / Search Terms

CE Concepts medical oncologists, thoracic surgeons, pulmonologists, radiation oncologists, molecular pathologists, early stage NSCLC, NSCLC, ADAURA, stage IB-IIIA EGFRm, EGFR-mutant, EGFR Free CE CME Live CE CME

Access Activity

CORE Higher Education Group,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps.CORE Higher Education Group,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the Terms of Service. Site Map